← FDA DRUG APPROVALS

FDA ANDA · ANDA070546

BRETYLIUM TOSYLATE

Sponsor: HIKMA

APPLICATION
ANDA070546
TYPE
ANDA
ORIGINAL APPROVAL
1986-05-14
LATEST ACTION
1994-06-22
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

BRETYLIUM TOSYLATEDiscontinued
BRETYLIUM TOSYLATE 50MG/ML · INJECTABLE · INJECTION

Approval history

1994-06-22Labeling · Supplement 6AP
1990-04-09Labeling · Supplement 4AP
1990-04-03Manufacturing (CMC) · Supplement 5AP
1989-01-24Manufacturing (CMC) · Supplement 3AP
1986-11-03Manufacturing (CMC) · Supplement 2AP
1986-06-04Labeling · Supplement 1AP
1986-05-14OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →